Cargando…
Insights into implementation of sacubitril/valsartan into clinical practice
BACKGROUND: Sacubitril/valsartan significantly reduced heart failure hospitalization and mortality in PARADIGM‐HF (Prospective Comparison of Angiotensin Receptor‐Neprilysin Inhibitor With an Angiotensin‐Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failur...
Autores principales: | Martens, Pieter, Beliën, Hanne, Dupont, Matthias, Mullens, Wilfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933963/ https://www.ncbi.nlm.nih.gov/pubmed/29464879 http://dx.doi.org/10.1002/ehf2.12258 |
Ejemplares similares
-
Implementation of sacubitril/valsartan in Sweden: clinical characteristics, titration patterns, and determinants
por: Fu, Michael, et al.
Publicado: (2020) -
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Practical guidance on the use of sacubitril/valsartan for heart failure
por: Sauer, Andrew J., et al.
Publicado: (2018) -
Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021) -
Eligibility and Usage of Sacubitril/Valsartan in Korea
por: Kim, Jin-Jin, et al.
Publicado: (2019)